Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors

Molecular and Cellular Biology

Volumn 23, Issue 23, 2003, Pages 8614-8625

  Man, Albert K ^a,b,f   Young, Lawrence J T ^c   Tynan, John A ^a,b   Lesperance, Jacqueline ^a   Egeblad, Mikala ^d   Werb, Zena ^d   Hauser, Craig A ^a   Muller, William J ^e   Cardiff, Robert D ^c   Oshima, Robert G ^a,b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f PREDICTIVE SCIENCE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; STROMELYSIN; TRANSCRIPTION FACTOR ETS 2; VASCULOTROPIN; VIRUS MIDDLE T ANTIGEN;

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER GRAFT; CARCINOGENESIS; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENE DELETION; GENE MUTATION; GENE TARGETING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STROMA; SUBSTITUTION REACTION; TRANSGENIC MOUSE;

ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GENE EXPRESSION; GENE TARGETING; HETEROZYGOTE; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PHOSPHORYLATION; PREGNANCY; PROTO-ONCOGENE PROTEIN C-ETS-2; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS MUSCULUS; POLYOMAVIRUS;

EID: 0242468991     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.23.8614-8625.2003     Document Type: Article

References (62)

1. ras mutants and c-ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:23589-23597.
2. Baker, K. M., G. Wei, A. E. Schaffner, and M. C. Ostrowski. 2003. Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J. Biol. Chem. 278:17876-17884.
3. Behrendtsen, O., C. M. Alexander, and Z. Werb. 1992. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114:447-456.
4. Benz, C. C., R. C. O'Hagan, B. Richter, G. K. Scott, C.-H. Chang, X. Xiong, K. Chew, B.-M. Ljung, S. Edgerton, A. Thor, and J. A. Hassell. 1997. HER2/Neu and the ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15:1513-1525.
5. Bergers, G., R. Brekken, G. McMahon, T. H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb, and D. Hanahan. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:737-744.
6. Bissell, M. J., and D. Radisky. 2001. Putting tumours in context. Nat. Rev. Cancer 1:46-54.
7. Boulukos, K. E., P. Pognonec, E. Sariban, M. Bailly, C. Lagrou, and J. Ghysdael. 1990. Rapid and transient expression of Ets2 in mature macrophages following stimulation with CMGF, LPS, and PKC activators. Genes Dev. 4:401-409.
8. Cheung, A. T. W., L. J. T. Young, P. C. Y. Chen, C. Y. Chao, A. Ndoye, P. A. Barry, W. J. Muller, and R. D. Cardiff. 1997. Microcirculation and metastasis in a new mouse mammary tumor model system. Int. J. Oncol. 11:69-77.
9. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Coussens, L. M., C. L. Tinkle, D. Hanahan, and Z. Werb. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490.
11. Dahl, J., R. Freund, J. Blenis, and T. L. Benjamin. 1996. Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase. Mol. Cell. Biol. 16:2728-2735.
12. Dankort, D., B. Maslikowski, N. Warner, N. Kanno, H. Kim, Z. Wang, M. F. Moran, R. G. Oshima, R. D. Cardiff, and W. J. Muller. 2001. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol. Cell. Biol. 21:1540-1551.
13. Dankort, D. L., and W. J. Muller. 2000. Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene 19:1038-1044.
14. -/- embryos. Development 124:279-287.
15. Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161-174.
16. Elenbaas, B., and R. A. Weinberg. 2001. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264:169-184.
17. Foos, G., J. J. Garcia-Ramirez, C. K. Galang, and C. A. Hauser. 1998. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J. Biol. Chem. 273:18871-18880.
18. Foos, G., and C. A. Hauser. 2000. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness. Oncogene 19:5507-5516.
19. Fowles, L. F., M. L. Martin, L. Nelsen, K. J. Stacey, D. Redd, Y. M. Clark, Y. Nagamine, M. McMahon, D. A. Hume, and M. C. Ostrowski. 1998. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 18:5148-5156.
20. Fujiwara, S., R. J. Fisher, N. K. Bhat, S. M. D. Espina, and T. S. Papas. 1988. A short-lived nuclear phosphoprotein encoded by the human ets-2 protooncogene is stabilized by activation of protein kinase C. Mol. Cell. Biol. 8:4700-4706.
21. Waf1/Cip1 promoter by the ets oncogene family transcription factor E1AF. Biochem. Biophys. Res. Commun. 236:79-82.
22. Galang, C. K., C. J. Der, and C. A. Hauser. 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-ets-2 binding sites. Oncogene 9:2913-2921.
23. Galang, C. K., J. J. Garcia-Ramirez, P. A. Solski, C. J. Der, N. N. Neznanov, R. G. Oshima, and C. A. Hauser. 1996. Oncogenic neu/ErbB-2 increases ets, AP-1, and NF-kB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem. 271:7992-7998.
24. Gum, R., E. Lengyel, J. Juarez, J. H. Chen, H. Sato, M. Seiki, and D. Boyd. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271:10672-10680.
25. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954-961.
26. Henkel, G. W., S. R. McKercher, H. Yamamoto, K. L. Anderson, R. G. Oshima, and R. A. Maki. 1996. PU.1 but not ets-2 is essential for macrophage development from ES cells. Blood 88:2917-2926.
27. Hever, A., R. G. Oshima, and C. A. Hauser. 2003. Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro. Exp. Cell Res. 290:132-143.
28. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
29. Hutchinson, J., J. Jin, R. D. Cardiff, J. R. Woodgett, and W. J. Muller. 2001. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell. Biol. 21:2203-2212.
30. Karim, F. D., L. D. Urness, C. S. Thummel, M. J. Klemsz, S. R. McKercher, A. Celada, C. VanBeveren, and R. A. Maki. 1990. The ets domain: a new DNA binding motif that recognizes a purine-rich core DNA sequence. Genes Dev. 4:1451-1453.
31. Langer, S. J., D. M. Bortner, M. F. Roussel, C. J. Sherr, and M. C. Ostrowski. 1992. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 12:5355-5362.
32. Lin, E. Y., A. V. Nguyen, R. G. Russell, and J. W. Pollard. 2001. Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193:727-740.
33. Lochter, A., S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M. J. Bissell. 1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139:1861-1872.
34. Luettke, N. C., H. K. Phillips, T. H. Qiu, N. G. Copeland, H. S. Earp, N. A. Jenkins, and D. C. Lee. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8:399-413.
35. Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene Int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352.
36. McCarthy, S. A., D. Chen, B.-S. Yang, J. J. Garcia Ramirez, H. Cherwinski, X.-R. Chen, M. Klagsbrun, C. A. Hauser, M. C. Ostrowski, and M. McMachon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401-2412.
37. Miller, F. R., D. Median, and G. H. Heppner. 1981. Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res. 41:3863-3867.
38. Neznanov, N., A. K. Man, H. Yamamoto, C. A. Hauser, R. D. Cardiff, and R. G. Oshima. 1999. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. Cancer Res. 59:4242-4246.
39. O'Gorman, S., N. A. Dagenais, M. Qian, and Y. Marchuk. 1997. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. USA 94:14602-14607.
40. O'Neill, E. M., I. Rebay, R. Tijan, and G. M. Rubin. 1994. The activities of two ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell 78:137-147.
41. a. Oshima, R. G., J. Lesperance, V. Munoz, L. Hebbard, B. Ranscht, N. Sharan, W. J. Muller, C.A. Hauser, and R. D. Cardiff. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis. Cancer Res., in press.
42. Patton, S. E., M. L. Martin, L. L. Nelsen, X. Fang, G. B. Mills, and M. C. Ostrowski. 1998. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines. Cancer Res. 58:2253-2259.
43. Samakovlis, C., G. Manning, P. Steneberg, N. Hacohen, R. Cantera, and M. A. Krasnow. 1996. Genetic control of epithelial tube fusion during Drosophila tracheal development. Development 122:3531-3536.
44. Scott, G. K., C. H. Chang, K. M. Erny, F. Xu, W. J. Fredericks, F. J. Rauscher, A. D. Thor, and C. C. Benz. 2000. Ets regulation of the erbB2 promoter. Oncogene 19:6490-6502.
45. Seidel, J. J., and B. J. Graves. 2002. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev. 16:127-137.
46. L-dependent mechanism. Mol. Cell. Biol. 19:2624-2634.
47. Sevilla, L., A. Zaldumbide, F. Carlotti, M. A. Dayem, P. Pognonec, and K. E. Boulukos. 2001. Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1. J. Biol. Chem. 276:17800-17807.
48. Shepherd, T. G., L. Kockeritz, M. R. Szrajber, W. J. Muller, and J. A. Hassell. 2001. The pea3 subfamily ets genes are required for HER2/Neumediated mammary oncogenesis. Curr. Biol. 11:1739-1748.
49. Siegel, P. M., D. L. Dankort, W. R. Hardy, and W. J. Muller. 1994. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14:7068-7077.
50. Smith, J. L., A. E. Schaffner, J. K. Hofmeister, M. Hartman, G. Wei, D. Forsthoefel, D. A. Hume, and M. C. Ostrowski. 2000. ets-2 is a target for an Akt (protein kinase B)/Jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol. Cell. Biol. 20:8026-8034.
51. Span, P. N., P. Manders, J. J. Heuvel, C. M. Thomas, R. R. Bosch, L. V. Beex, and C. G. Sweep. 2002. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21:8506-8509.
52. Sternlicht, M. D., A. Lochter, C. J. Sympson, B. Huey, J. P. Rougier, J. W. Gray, D. Pinkel, M. J. Bissell, and Z. Werb. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137-146.
53. Tanaka, S., T. Kunath, A. K. Hadjantonakis, A. Nagy, and J. Rossant. 1998. Promotion of trophoblast stem cell proliferation by FGF4. Science 282:2072-2075.
54. Trimble, M. S., J.-H. Xin, C. T. Guy, W. J. Muller, and J. A. Hassell. 1993. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene 8:3037-3042.
55. Venter, J. C., M. D. Adams, E. W. Myers, P. W. Li, R. J. Mural, G. G. Sutton, H. O. Smith, M. Yandell, C. A. Evans, R. A. Holt, J. D. Gocayne, P. Amanatides, R. M. Ballew, D. H. Huson, J. R. Wortman, Q. Zhang, C. D. Kodira, X. H. Zheng, L. Chen, M. Skupski, G. Subramanian, P. D. Thomas, J. Zhang, G. L. Gabor Miklos, C. Nelson, S. Broder, A. G. Clark, J. Nadeau, V. A. McKusick, N. Zinder, A. J. Levine, R. J. Roberts, M. Simon, C. Slayman, M. Hunkapiller, R. Bolanos, A. Delcher, I. Dew, D. Fasulo, M. Flanigan, L. Florea, A. Halpern, S. Hannenhalli, S. Kravitz, S. Levy, C. Mobarry, K. Reinert, K. Remington, J. Abu-Threideh, E. Beasley, K. Biddick, V. Bonazzi, R. Brandon, M. Cargill, I. Chandramouliswaran, R. Charlab, K. Chaturvedi, Z. Deng, V. Di Francesco, P. Dunn, K. Eilbeck, C. Evangelista, A. E. Gabrielian, W. Gan, W. Ge, F. Gong, Z. Gu, P. Guan, T. J. Heiman, M. E. Higgins, R. R. Ji, Z. Ke, K. A. Ketchum, Z. Lai, Y. Lei, Z. Li, J. Li, Y. Liang, X. Lin, F. Lu, G. V. Merkulov, N. Milshina, H. M. Moore, A. K. Naik, V. A. Narayan, B. Neelam, D. Nusskern, D. B. Rusch, S. Salzberg, W. Shao, B. Shue, J. Sun, Z. Wang, A. Wang, X. Wang, J. Wang, M. Wei, R. Wides, C. Xiao, C. Yan, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
56. Watabe, T., K. Yoshida, M. Shindoh, M. Kaya, K. Fujikawa, H. Sato, M. Seiki, S. Ishi, and K. Fujinaga. 1998. The ets-1 and ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 77:128-137.
57. Webster, M. A., J. N. Hutchinson, M. J. Rauh, S. K. Muthuswamy, M. Anton, C. G. Tortorice, R. D. Cardiff, F. L. Graham, J. A. Hassell, and W. J. Muller. 1998. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:2344-2359.
58. Wiseman, B. S., and Z. Werb. 2002. Stromal effects on mammary gland development and breast cancer. Science 296:1046-1049.
59. Cip1. Mol. Cell. Biol. 17:5598-5611.
60. Yamamoto, H., M. L. Flannery, S. Kupriyanov, J. Pearce, S. R. McKercher, G. W. Henkel, R. A. Maki, Z. Werb, and R. G. Oshima. 1998. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12:1315-1326.
61. Yang, B.-S., C. A. Hauser, G. Henkel, M. S. Colman, C. Van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activity of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538-547.
62. Young, L. J. T. 2000. The cleared mammary fat pad and the transplantation of mammary gland morphological structures and cells, p. 67-74. In M. Ip and B. Asch (ed.), Methods in mammary gland biology and breast cancer research. Kluwer Academic/Plenum Publishers, New York, N.Y.